Guangdong Taienkang Pharmaceutical Co. Ltd (301263) — Financial Flexibility Index
Guangdong Taienkang Pharmaceutical Co. Ltd (301263) has a Financial Flexibility Index of 0.14x as of December 2025. Free cash flow of CN¥95.40 Million (operating CF CN¥-12.88 Million minus capex CN¥108.28 Million) represents 0% of total liabilities (CN¥676.07 Million). Check Guangdong Taienkang Pharmaceutical Co. L investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Guangdong Taienkang Pharmaceutical Co. Ltd Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Guangdong Taienkang Pharmaceutical Co. Ltd across 7 annual periods. For the full cash flow conversion analysis, see Guangdong Taienkang Pharmaceutical Co. L operating cash flow efficiency.
Annual Financial Flexibility Index for Guangdong Taienkang Pharmaceutical Co. Ltd (2019–2025)
Year-by-year free cash flow to debt coverage for Guangdong Taienkang Pharmaceutical Co. Ltd. Explore cash flow to debt ratio of Guangdong Taienkang Pharmaceutical Co. L to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.14x | CN¥95.40 Million | CN¥-12.88 Million | CN¥676.07 Million | ▼ -55.8% |
| 2024 | 0.32x | CN¥157.88 Million | CN¥89.33 Million | CN¥494.67 Million | ▼ -56.5% |
| 2023 | 0.73x | CN¥293.53 Million | CN¥93.53 Million | CN¥399.72 Million | ▼ -42.9% |
| 2022 | 1.29x | CN¥238.69 Million | CN¥148.81 Million | CN¥185.63 Million | ▲ +80.9% |
| 2021 | 0.71x | CN¥164.67 Million | CN¥120.02 Million | CN¥231.71 Million | ▼ -20.3% |
| 2020 | 0.89x | CN¥218.65 Million | CN¥125.53 Million | CN¥245.12 Million | ▲ +91.7% |
| 2019 | 0.47x | CN¥84.27 Million | CN¥75.44 Million | CN¥181.16 Million | — |